Skip to content

Price / sales at other companies

AMN Healthcare logo
AMN HealthcareAMN
0.2×-0.1×
Teladoc Health logo
Teladoc HealthTDOC
0.4×-0.2×
Cencora logo
CencoraCOR
0.2×0.0×
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
0.7×-0.4×
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
1.2×0.0×
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
1.2×-0.2×

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%
EPS (diluted)-$0.14-600%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Return on equity-27%-32.7pp
Debt / equity0.0×
Current ratio3.3×+0.3×

Where this comes from

Calculated from Cross Country Healthcare’s reported figures.

Based on the most recent quarter.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's price / sales?
Cross Country Healthcare (CCRN) reported price / sales of 0.3× in Q1 2026.
How has Cross Country Healthcare's price / sales changed year-over-year?
Cross Country Healthcare's price / sales decreased by 21.9% year-over-year, from 0.4× to 0.3×.
What is the long-term trend for Cross Country Healthcare's price / sales?
Over 5 years (2020 to 2025), Cross Country Healthcare's price / sales has grown at a -9.0% compound annual growth rate (CAGR), from 0.4× to 0.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.